UNLABELLED: Fluorinated m-tyrosine analogs were evaluated as PET imaging agents and compared with 6-fluoroDOPA in the visualization of dopamine nerve terminals. METHODS: The three m-tyrosine analogs, 6-[18F]fluoro-L-m-tyrosine (6-FMT), 2-[18F]fluoro-L-m-tyrosine (2-FMT) and 6-[18F]fluoro-fluoromethylene-DL-m-tyrosine (6-F-FMMT), were prepared via electrophilic radiofluorination using [18F]acetylhypofluorite. These three analogs, as well as 6-[18F]fluoro-L-DOPA (6-FD), were injected into sets of rhesus monkeys, and serial PET images were acquired. Plasma samples were collected at different times after tracer administration, and metabolite analyses were done using high-performance liquid chromatography (HPLC). RESULTS: Visual inspection of the PET images obtained using these four tracers showed that the best image contrast was obtained with 6-FMT. Patlak analysis with a reference tissue input function yielded a mean uptake rate constant for 6-FMT of 0.019 min-1, a value twice those for the other tracers including 6-FD. CONCLUSION: These results demonstrate the superiority of 6-[18F]FMT in visualizing dopamine terminals in the rhesus monkey brain and suggest that 6-[18F]FMT is the tracer of choice in the assessment of dopamine metabolism in the living human brain.
UNLABELLED: Fluorinated m-tyrosine analogs were evaluated as PET imaging agents and compared with 6-fluoroDOPA in the visualization of dopamine nerve terminals. METHODS: The three m-tyrosine analogs, 6-[18F]fluoro-L-m-tyrosine (6-FMT), 2-[18F]fluoro-L-m-tyrosine (2-FMT) and 6-[18F]fluoro-fluoromethylene-DL-m-tyrosine (6-F-FMMT), were prepared via electrophilic radiofluorination using [18F]acetylhypofluorite. These three analogs, as well as 6-[18F]fluoro-L-DOPA (6-FD), were injected into sets of rhesus monkeys, and serial PET images were acquired. Plasma samples were collected at different times after tracer administration, and metabolite analyses were done using high-performance liquid chromatography (HPLC). RESULTS: Visual inspection of the PET images obtained using these four tracers showed that the best image contrast was obtained with 6-FMT. Patlak analysis with a reference tissue input function yielded a mean uptake rate constant for 6-FMT of 0.019 min-1, a value twice those for the other tracers including 6-FD. CONCLUSION: These results demonstrate the superiority of 6-[18F]FMT in visualizing dopamine terminals in the rhesus monkey brain and suggest that 6-[18F]FMT is the tracer of choice in the assessment of dopamine metabolism in the living human brain.
Authors: Mary L Schneider; Colleen F Moore; Lisa L Gajewski; Julie A Larson; Andrew D Roberts; Alexander K Converse; Onofre T DeJesus Journal: Child Dev Date: 2008 Jan-Feb
Authors: Claire J Ciampa; Jourdan H Parent; Molly R Lapoint; Kaitlin N Swinnerton; Morgan M Taylor; Victoria R Tennant; A J Whitman; William J Jagust; Anne S Berry Journal: Cereb Cortex Date: 2022-06-16 Impact factor: 4.861
Authors: Meredith N Braskie; Claire E Wilcox; Susan M Landau; James P O'Neil; Suzanne L Baker; Cindee M Madison; Jennifer T Kluth; William J Jagust Journal: J Neurosci Date: 2008-12-24 Impact factor: 6.167
Authors: Ronald L Klein; Robert D Dayton; Tracee L Terry; Chris Vascoe; John J Sunderland; Kerrie H Tainter Journal: Brain Res Date: 2009-02-10 Impact factor: 3.252
Authors: Deanna L Wallace; Esther Aarts; Linh C Dang; Stephanie M Greer; William J Jagust; Mark D'Esposito Journal: PLoS One Date: 2014-05-07 Impact factor: 3.240
Authors: Di Cui; Andrea Mesaros; Gregor Burdeos; Ingo Voigt; Patrick Giavalisco; Yvonne Hinze; Martin Purrio; Bernd Neumaier; Alexander Drzezga; Yayoi Obata; Heike Endepols; Xiangru Xu Journal: Int J Mol Sci Date: 2020-08-31 Impact factor: 5.923